Novozymes buys Irish probiotic maker PrecisionBiotics

Danish enzyme maker Novozymes will buy Ireland-based PrecisionBiotics in a $90 million deal, it said on Thursday, its second acquisition of a probiotics company in recent years as it seeks to grow its human health business. "The presence that we have today in human health is small, and this is why we are coming with an acquisition to get the critical mass, to drive the momentum," newly appointed chief executive Ester Baiget told Reuters. Baiget, who took over the helm of Novozymes in February, said the main focus was on growth, both in the top line and profitability..
Danish enzyme maker Novozymes will buy Ireland-based PrecisionBiotics in a $90 million deal, it said on Thursday, its second acquisition of a probiotics company in recent years as it seeks to grow its human health business. The presence that we have today in human health is small, and this is why we are coming with an acquisition to get the critical mass, to drive the momentum, newly appointed chief executive Ester Baiget told Reuters. Baiget, who took over the helm of Novozymes in February, said the main focus was on growth, both in the top line and profitability..
Danish enzyme maker Novozymes will buy Ireland-based PrecisionBiotics in a $90 million deal, it said on Thursday, its second acquisition of a probiotics

About Novozymes.

Novozymes Agrees to Buy Chr. Hansen in $12.3 Billion Deal

Detailed mapping of Bifidobacterium strain transmission from

About Novozymes.

Novozymes acquires PrecisionBiotics

Novozymes — Wikipédia

Immune by PrecisionBiotics - Unique Bifidobacterium Longum Strain

Novozymes - Recent News & Activity

Novozymes acquires PrecisionBiotics to harness probiotic-enzyme

Immune by PrecisionBiotics - Unique Bifidobacterium Longum Strain

Danish enzyme producer Novozymes acquires probiotic solution

Ulrich Irgens posted on LinkedIn